Compare ARK Genomic Revolution ETF (ARKG) vs Avantis International Small Cap Value ETF (AVDV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Avantis International Small Cap Value ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Avantis International Small Cap Value ETF trades at $104.2. Which is the better fit depends on your goals.
| ARKG | AVDV | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $110.40 |
52-Week Low | $23.09 | $80.02 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
AVDV trades at $104.2, up 1.04% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF focuses on international small-cap value stocks from developed markets, offering diversification and a modest dividend, with a $1.39 dividend scheduled for June 2026. Recent news highlights its 35% gains in 2026, outperforming the S&P 500 by 5.7%, though some analysts express caution about cyclical reliance.
The outlook is mixed: strong recent performance and institutional interest support upside, but bearish technicals and concerns over structural alpha pose risks. Investors should weigh the ETF's value approach against potential volatility from international markets and sector cycles.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Avantis International Small Cap Value ETF
AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.
Read more on AVDV →
